IRVING, Texas----The Journal of the American Society of Clinical Oncology has published the early results of a clinical study conducted by Dr. Siu-Fun Wong, and her colleagues, which concluded that the topical gel, Regenecare®, caused a statistically significant reduction in the pain and itching of a rash that results from the use of anti-cancer drugs known as EGFR inhibitors.
From: biz.yahoo.com
R) Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
Posted by Ruslan Abuzant at 10:50 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment